Think About the Future
As we imagine the world in the post-COVID-19 era, we wonder more about who should help us fight off infections and other diseases. We wonder who will be responsible for curing such terrible diseases as cancer or Alzheimer’s. All of these questions lead us to look for ways to improve our health, find ways to lower our blood sugar, and eat healthier.
We do not know our future, and we worry about making ourselves comfortable and prepared. However, this race can be exhausting, can’t it? However, we can offer a solution to this race and reduce our shared fears about the future.
Who We Are
We have all become wary of pharmaceutical companies offering us pills as a magic cure for every disease. This is not the case, and we strive to prove the importance of responsible medicine and technology. For almost 15 years, BioNTech SE has been effectively using technology in medicine, developing its initiatives, and organizing research to obtain results with strong evidence. The company strives to show that the production of drugs and vaccines is a combination of science and art, which requires the aspiration and knowledge of society. Through effective technology integration on the market, drug distribution, and continuous development, BioNTech SE generated revenues of almost EUR 20 billion in 2021 (BioNTech, 2022).
History of the Journey
Our history is not as long as it may seem, but we have accomplished much during this period. We have gone from a small production facility to one of the largest companies with tremendous revenues that allow us to continue to grow. We have developed products, built new factories, and will continue to expand. Our goal is cooperation, which will ensure healthy competition and a great business strategy. We are a company that sees a happy and promising future because we focus on technology and communicating with our customers.
Our Numbers
Talking about the company’s success, it is necessary to show how well the performance now corresponds to efficient work. BioNTech SE has significantly increased its profits, according to many stock analyses over the past few years. By the end of 2022, figures such as a stock increase of 400 percent or more have been heard. This performance is a credit to the development and competent trading on the stock exchange and interaction in the media space.
Business Dynamics
BioNTech SE sees itself as a source for meeting basic needs: healthy development and organizing care. It is an approach based on humanity and the value of human life, respect for technology, and ethics that allows BioNTech SE to market its product and achieve truly ethical goals successfully. Just as we cannot imagine life without a polio shot, we cannot imagine BioNTech SE giving up empathy in favor of sales.
Technology and Humanity
As we develop technology, we become the source of health services that can improve health. We create a structure by constantly integrating new technological tools (pipettes and centrifuges) and improving technical equipment and research methods (types of spectrophotometry and synthesis) into our practice. Our structure is a fundamental tool for managing success and innovation.
Listening to our colleagues, discussing our potential, and looking for new ways to help the community. While the goal of helping everyone seems unattainable, we want to provide as much quality coverage as possible. Sometimes, the value of a cure is not understood until one encounters the disease directly, but the manufacturer should always keep it in mind.
Goals
Like any other organization, we want to increase our profits to create more valuable products in the future. Based on our pharmaceutical manufacturing vision, values, and mission, it is obvious why we have such global, long-term goals. Achieving them will take much effort, but we plan to work consistently and expand our capabilities. Our main business goal is to increase the value of our products for the customer.
Achieving the Goals
First, we will establish planning and funding sources to achieve our long- and short-term goals and provide ourselves with a safety cushion. Second, we will establish a dedicated team and control groups to assess business dynamics processes. Short-term goals are scheduled to be achieved by the end of the current fiscal period, and long-term goals, depending on the task, range from 3-4 years to 10 years.
Our Course of Action
Our vision and values guide us in achieving our goals because they dictate the way. BioNTech SE is a company where every action must be justified and linked to the core business objective of improving public health. Without a constant focus on this goal, we would not have our current success and health indicators after COVID-19. Biotechnology is constantly evolving and improving, and BioNTech SE is committed to following all innovations and incorporating them into our work to satisfy consumers.
Where Are We Going?
The simple answer about our direction lies in SDG 3—providing affordable health care to all people worldwide and services to improve the quality of health. We strive to create an environment where cancer is no longer dead, and millions of people can get help on time. We take it upon ourselves to pursue this path as long and effectively as possible. It may take generations of researchers before we fully unravel the mystery of cancer treatment, but we will never stop and move closer to that goal with each step.
Confronting Risks
Like any company, we assess risks and seek to minimize their effects. We cannot fully imagine the potential barriers to achieving our goals, but we strive to ensure that the brainstorming and planning stages are transparent and clear. There is no unique and workable way to prevent risks and keep production without losses. Nevertheless, we are reinforcing risk management to focus our energies on solving a problem when necessary.
A Few More Things
During its existence, BioNTech has gained invaluable experience in innovation management and implementation. In addition, we have learned to understand what consumers want and how we can help them achieve our shared interest in better health. Our success results from our development, our ability to listen to our customers, to allocate financing, and to manage risk. We have charted a path forward and many great goals that we will surely achieve because BioNTech combines passion, science, and cooperation.
References
Adams, B. (2022). Pfizer and BioNTech go to Hollywood with splashy Oscars sponsorship. Fierce Pharma. Web.
BioNTech. (2020). Sustainability report. Investors BioNTech. Web.
BioNTech. (2021). Management report on the group and the company for the 2020 financial year. Investors BioNTech. Web.
BioNTech. (2022). Combined management report for the 2021 financial year. Investors BioNTech. Web.
BioNTech. (2023). Press release: BioNTech to report full-year and fourth quarter 2022 financial results and operational update on March 27, 2023. Investors BioNTech. Web.
BioNTech. (n.d. a). Corporate social responsibility. BioNTech. Web.
BioNTech. (n.d. b). Vision & mission. BioNTech. Web.